Unknown PHASE3 INTERVENTIONAL 3-arm NCT00800423

Effect of Topical Brimonidine on Post Cataract Surgery Corneal Edema

Phase 3 Study of Brimonidine Tartrate Drops Efficacy in Reducing Post Operative Corneal Edema After Cataract Surgery

Sponsor: Rabin Medical Center

Interventions Brimonidine Tartrate 0.2% Timolol maleate 0.5%

Updated 6 times since 2017 Last updated: Dec 1, 2008 Started: Jan 31, 2009 Primary completion: Jan 31, 2010 Completion: Jan 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00800423, this PHASE3 trial focuses on Corneal Edema and Visual Acuity and remains ongoing. Sponsored by Rabin Medical Center, it has been updated 6 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE3
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rabin Medical Center

Data source: Rabin Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Petah Tikva, Israel